Prospective, randomized comparison of sequential intravenous followed by oral ciprofloxacin with intravenous ceftazidime in the treatment of serious infections
Authors:
- P.SAmuel PegramPPP.SAmuel Pegram
- Stephen F. WeberSWStephen F. Weber
- Peter A. LeonePLPeter A. Leone
- 1 November 1989
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Medicine
- Vol. 87 (5) , S185-S190
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- The enterococcus: High-level resistance to gentamicin and production of beta-lactamaseClinical Microbiology Newsletter, 1988
- Ciprofloxacin: In Vitro Activity, Mechanism of Action, and ResistanceClinical Infectious Diseases, 1988
- Efficacy, Safety, and Potential Economic Benefits of Oral Ciprofloxacin in the Treatment of InfectionsClinical Infectious Diseases, 1988
- Randomized trial of beta-lactam regimens in febrile neutropenic cancer patientsThe American Journal of Medicine, 1988
- Beta-Lactam AntibioticsNew England Journal of Medicine, 1988
- Beta-Lactam AntibioticsNew England Journal of Medicine, 1988
- A Randomized Trial Comparing Ceftazidime Alone with Combination Antibiotic Therapy in Cancer Patients with Fever and NeutropeniaNew England Journal of Medicine, 1986
- The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitroAntimicrobial Agents and Chemotherapy, 1985
- Approaching the controversies in antibacterial management of cancer patientsThe American Journal of Medicine, 1984
- The New Beta-Lactamase-Stable CephalosporinsAnnals of Internal Medicine, 1982